Skip to main navigation
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2024
Resources
All Resources
2024 Savings Report
Drug Shortages White Paper
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Search
Close
Breadcrumb
Association for Accessible Medicines
Resources
Resources
Share
Find up-to-date information on generics and biosimilars
Filter Resources
Issues
Biosimilar User Fee Act (BsUFA)
Biosimilars
Complex Generics
Drug Approval Process (GDUFA)
Drug Prices
Drug Shortages
Generic Drug Labeling
Generic Supply Chain
IP Issues
Low Income Subsidies (LIS in Part D)
Medicaid
Medicare
NAFTA
Patent Reform
Patient Stories
Pharmaceutical Waste Take Back
Preventing Drug Abuse
Quality
REMS/Sample Acquisition Remedies
State Initiatives
Tariffs
Trade
Transparency
User Fees
Resource Type
Blog
Amicus Brief
Press Release
Infographic
Video
Report
Fact Sheet
Presentation
Amicus Brief
Feb 6, 2017
| Erica Klinger
TC HEARTLAND, LLC D/B/A HEARTLAND FOOD PRODUCTS GROUP v. KRAFT FOODS GROUP BRANDS LLC
Press Release
Jan 18, 2017
| Erica Klinger
Statement by Chip Davis, President and CEO, AAM, on HHS Secretary Nominee Tom Price
Press Release
Jan 11, 2017
| Erica Klinger
AAM Statement Regarding President-Elect Trump’s Remarks on the Pharmaceutical Industry
Report
Jan 1, 2016
| Erica Klinger
2015 Annual Report
Report
Jan 1, 2015
| Erica Klinger
2014 Annual Report
Report
Jan 1, 2014
| Erica Klinger
2013 Annual Report
Report
Jan 8, 2013
| Erica Klinger
2012 Annual Report
Report
Jan 8, 2012
| Erica Klinger
2011 Annual Report
Report
Jan 8, 2011
| Erica Klinger
2010 Annual Report
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2024
Resources
All Resources
2024 Savings Report
Drug Shortages White Paper
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action